The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 10, 2023
Filed:
Jul. 14, 2022
Applicant:
Siga Technologies, Inc., Corvallis, OR (US);
Inventors:
Shanthakumar R. Tyavanagimatt, Sammamish, WA (US);
Kris Holt, Colorado Springs, CO (US);
Ying Tan, Millbrae, CA (US);
Melialani A. C. L. S. Anderson, Corvallis, OR (US);
Dennis E. Hruby, Albany, OR (US);
Assignee:
Siga Technologies, Inc., Corvallis, OR (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/403 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 47/26 (2006.01); A61K 47/34 (2017.01); A61K 47/38 (2006.01);
U.S. Cl.
CPC ...
A61K 31/403 (2013.01); A61K 9/0053 (2013.01); A61K 9/0095 (2013.01); A61K 9/16 (2013.01); A61K 47/26 (2013.01); A61K 47/34 (2013.01); A61K 47/38 (2013.01);
Abstract
The present invention is directed to a dry suspension for reconstitution containing Tecovirimat (ST-246) powder and simethicone. The dry suspension is dispersed in water to provide an aqueous pharmaceutical suspension formulation for oral administration for treating orthopoxvirus infections and/or eczema vaccinatum. The suspension formulation exhibits excellent stability and good dissolution and has an improved taste and texture.